206-137-4

Applied Filters:

Keyword:'206-137-4'

Showing 1-3 of 3 results for "206-137-4" within Papers

MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate.

Lena Smirnova et al.

PloS one, 9(6), e98892-e98892 (2014-06-05)

Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the

Incremental large and small muscle mass exercise in patients with heart failure: evidence of preserved peripheral haemodynamics and metabolism.

F Esposito et al.

Acta physiologica (Oxford, England), 213(3), 688-699 (2014-11-14)

Doubt still remains as to whether peripheral vascular and skeletal muscle dysfunction accompanies the compromised cardiac function associated with heart failure with reduced ejection fraction (HFrEF). The aim of this study was to examine the effect of HFrEF on the

Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.

Christina Yoon et al.

Journal of acquired immune deficiency syndromes (1999), 65(5), 551-556 (2013-12-19)

Symptom-based tuberculosis screening identifies less than one-third of eligible HIV-infected patients as candidates for isoniazid preventive therapy (IPT). We evaluated whether testing for C-reactive protein (CRP) improves patient selection for IPT. We measured CRP levels (normal <10 mg/L) using a

Page 1 of 1